Pulmonary hypertension of sickle cell disease: More than just another lung disease

American Journal of Hematology

Volumn 83, Issue 1, 2008, Pages 4-5

  Klings, Elizabeth S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; HEMOGLOBIN S; HEMOGLOBIN VARIANT; PROSTACYCLIN; SILDENAFIL;

AFRICA; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SICKLE CELL ANEMIA; SURVIVAL; TRICUSPID VALVE REGURGITATION;

ANEMIA, SICKLE CELL; HUMANS; HYPERTENSION, PULMONARY;

EID: 38349003103     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21083     Document Type: Review

References (11)

1. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;tplay -"O_Footer"350:886-895.
2. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. Br J Haematol 2006;134:109-115.
3. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43 (12 Suppl S):40S-47S.
4. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 2007;175:1272-1279.
5. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical guidelines. Chest 2004;126 (Suppl):78S-92S.
6. Aliyu ZY, Kato GJ, Taylor J VI, et al. Sickle cell disease and pulmonary hypertension in Africa: A global perspective and review of epidemiology, pathophysiology and management. Am J Hematol 2007 (in press).
7. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47.
8. Taylor J VI, Woods GM, Machado R, et al. Severe pulmonary hypertension in an adolescent with sickle cell disease. Am J Hematol 2007. DOI: 10.1002/ajh.21039.
9. Kato GJ, Onyekwere OC, Gladwin MT. Pulmonary hypertension in sickle cell disease: Relevance to children. Pediatr Hematol Oncol 2007;24:159-170.
10. DeCastro LM, Jonassaint JC, Graham FL, et al. Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. Am J Hematol 2007. DOI: 10.1002/ajh.21058
11. Gordeuk VR, Sachdev V, Taylor J, et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 2007. DOI: 10.1002/ajh.21016.